374 related articles for article (PubMed ID: 27867264)
21. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kwon SS; Kim JH; Jeong HU; Cho YY; Oh SR; Lee HS
Molecules; 2016 Apr; 21(5):. PubMed ID: 27128896
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters.
Park EJ; Park R; Jeon JH; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138123
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Investigation of Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes.
Ji SB; Park SY; Bae S; Seo HJ; Kim SE; Lee GM; Wu Z; Liu KH
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575495
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
25. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
26. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
Robertson P; DeCory HH; Madan A; Parkinson A
Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory Effects of
Seo HJ; Ji SB; Kim SE; Lee GM; Park SY; Wu Z; Jang DS; Liu KH
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802239
[No Abstract] [Full Text] [Related]
29. Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes.
Liu X; Wang Q; Chen M; Tao J; Wang J; Liu S; Hou J; Li D; Wang R
J Ethnopharmacol; 2023 May; 308():116303. PubMed ID: 36841379
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays.
Xing Y; Yu Q; Zhou L; Cai W; Zhang Y; Bi Y; Zhang Y; Fu Z; Han L
Phytomedicine; 2023 Apr; 112():154710. PubMed ID: 36805481
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
[TBL] [Abstract][Full Text] [Related]
35. In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450.
Winitthana T; Niwattisaiwong N; Patarapanich C; Tantisira MH; Lawanprasert S
Toxicol In Vitro; 2011 Jun; 25(4):890-6. PubMed ID: 21349323
[TBL] [Abstract][Full Text] [Related]
36.
Li L; Luo X; Cheng Z
Xenobiotica; 2021 Jul; 51(7):745-751. PubMed ID: 32897767
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
38. Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology.
Drozdzik M; Lapczuk-Romanska J; Wenzel C; Szelag-Pieniek S; Post M; Skalski Ł; Kurzawski M; Oswald S
Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575411
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
40. Safety assessment of Oryeong-san, a traditional herbal formula: Study of subacute toxicity and influence of cytochrome P450s and UDP-glucuronosyltransferases.
Jeon WY; Jin SE; Lee MY; Seo CS; Shin HK; Kim YB; Ha H
Regul Toxicol Pharmacol; 2018 Oct; 98():88-97. PubMed ID: 30026136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]